Related Experiment Video
Updated: Jan 31, 2026

Using Alizarin Red Staining to Detect Chemically Induced Bone Loss in Zebrafish Larvae
Published on: December 28, 2021
[Cancer Treatment-Induced Bone Loss(CTIBL)]
Seiji Fukumoto1, Toshio Matsumoto
1Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University.
Abstract:
Cancer treatment-induced bone loss(CTIBL)is becoming a big problem with advancement of cancer treatment, increase of patients suffering from cancers and improvement of survival of these patients. Clinically, bone loss in patients with breast or prostate cancers taking hormone therapy is the most frequent problem. It has been reported that bisphosphonates and denosumab prevent the bone loss and fractures in a part of these patients. Some guidelines concerning CTIBL have been published by several foreign societies. In addition, bone loss and fractures in patients receiving hormone therapy are mentioned in the clinical practice guidelines by Japanese Breast Cancer Society and The Japanese Urological Association. However, there are some discrepancies in the evaluation and treatment of the patients in these guidelines. It is necessary to establish a management plan for patients with CTIBL in Japan in the future.
Related Concept Videos
Treatment Resistant Cancers
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Mechanisms of Retrovirus-induced Cancers
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Energy Losses in Transformers
There are four main reasons for energy losses in transformers.
The first cause can be the high resistance of the...
Major Losses in Pipes
Fluid flow can be classified as laminar or turbulent, primarily based on the Reynolds number. This dimensionless number reflects the relative influence of inertial to viscous...

